PSMA Therapy for Metastatic Prostate Cancer
A targeted, infused therapy that delivers radiation directly to cancerous cells has been shown to extend survival in many patients with metastatic prostate cancer. The
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Patients receiving treatment from Regional Cancer Care Associates in Moorestown are in good hands. Five of its physicians — Dr. Seth Berk, Dr. Maurice Cairoli, Dr. James Lee, Dr. Rachel Levenbach and Dr. Stephen Wallace — were recently recognized by South Jersey Magazine as Top Physicians for Women for 2025.
The five have been recognized by the magazine in the past, proving that RCCA’s physicians are consistently recognized as leaders in cancer care. It is their compassion and focus on the patient’s needs that allows them to provide a uniquely personal approach to cancer care.
Regional Cancer Care Associates in Moorestown helps patients navigate the complex world of cancer treatment. From initial diagnosis to working through a complete cancer care plan, every step of a patient’s cancer journey is handled with compassion by a team dedicated to your success.
These physicians are among the more than 100 medical oncologists and hematologists who practice with RCCA at 25 locations across New Jersey, Connecticut, Massachusetts, Maryland, and the Washington, D.C., area. RCCA’s cancer specialists see more than 30,000 new patients each year and provide care to more than 265,000 established patients, collaborating closely with those patients’ other physicians.
RCCA physicians offer patients innovative therapies, including immunotherapies and targeted therapy, as well as access to approximately 300 clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, iron-deficiency anemia, and rheumatoid arthritis—who take intravenously-administered medications.
To learn more about RCCA, call 844-346-7222, contact us or request an appointment.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
A targeted, infused therapy that delivers radiation directly to cancerous cells has been shown to extend survival in many patients with metastatic prostate cancer. The
The world of cancer treatment is rapidly evolving. New therapies are being discovered, and existing ones have improved, resulting in better patient outcomes. Regional Cancer
The imaging tests were negative, but Elizabeth Whalen knew something was wrong. Having survived pancreatic cancer and breast cancer, the Cape May Court House resident was
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.